Cargando…

Investigation of the Characteristics of New, Uniform, Extremely Small Iron-Based Nanoparticles as T1 Contrast Agents for MRI

OBJECTIVE: The purpose of this study was to evaluate the magnetic resonance (MR) characteristics and applicability of new, uniform, extremely small iron-based nanoparticles (ESIONs) with 3–4-nm iron cores using contrast-enhanced magnetic resonance angiography (MRA). MATERIALS AND METHODS: Seven type...

Descripción completa

Detalles Bibliográficos
Autores principales:	So, Young Ho, Lee, Whal, Park, Eun-Ah, Kim, Pan Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Radiology 2021
Materias:	Technology, Experiment, and Physics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484154/ https://www.ncbi.nlm.nih.gov/pubmed/34402245 http://dx.doi.org/10.3348/kjr.2020.1455

Ejemplares similares

Management of Adverse Reactions to Iodinated Contrast Media for Computed Tomography in Korean Referral Hospitals: A Survey Investigation
por: Han, Seungchul, et al.
Publicado: (2019)

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023)

Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2020)

Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T(2) Contrast Agents for MRI
por: Martínez-González, Raquel, et al.
Publicado: (2016)

Iron Oxide as an MRI Contrast Agent for Cell Tracking
por: Korchinski, Daniel J., et al.
Publicado: (2015)

New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles
por: Gonzalez-Rodriguez, Roberto, et al.
Publicado: (2018)

Polymer-coated superparamagnetic iron oxide nanoparticles as T(2) contrast agent for MRI and their uptake in liver
por: Ali, Lamiaa MA, et al.
Publicado: (2017)

Effects of iron oxide nanoparticles as T(2)-MRI contrast agents on reproductive system in male mice
por: Yang, Heyu, et al.
Publicado: (2022)

Cubic Iron Core–Shell Nanoparticles Functionalized to Obtain High-Performance MRI Contrast Agents
por: Volokhova, Maria, et al.
Publicado: (2022)

Correction to: Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2021)

Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking
por: Li, Li, et al.
Publicado: (2013)

Effects of PEG Chain Length on Relaxometric Properties of Iron Oxide Nanoparticles-Based MRI Contrast Agent
por: Ge, Jianxian, et al.
Publicado: (2022)

Block Time: A Multispecialty Systematic Review of Efficacy and Safety of Ultrasound-guided Upper Extremity Nerve Blocks
por: Haley, Campbell Belisle, et al.
Publicado: (2023)

Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool
por: Uchiyama, Mayara Klimuk, et al.
Publicado: (2015)

Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies
por: Iancu, Stefania D, et al.
Publicado: (2020)

Machine Learning Improves Functional Upper Extremity Use Capture in Distal Radius Fracture Patients
por: Sequeira, Sean B., et al.
Publicado: (2022)

Iron(iii) chelated paramagnetic polymeric nanoparticle formulation as a next-generation T(1)-weighted MRI contrast agent
por: Marasini, Ramesh, et al.
Publicado: (2021)

Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer’s Disease
por: Ulanova, Marina, et al.
Publicado: (2023)

T(1)–T(2) Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
por: Szpak, Agnieszka, et al.
Publicado: (2014)

Macromolecules with Different Charges, Lengths, and Coordination Groups for the Coprecipitation Synthesis of Magnetic Iron Oxide Nanoparticles as T(1) MRI Contrast Agents
por: Tao, Cheng, et al.
Publicado: (2019)

MRI contrast enhancement of liver pre-neoplasia using iron–tannic nanoparticles
por: Phatruengdet, Thipjutha, et al.
Publicado: (2020)

New Strategies to Prolong the In Vivo Life Span of Iron-Based Contrast Agents for MRI
por: Antonelli, Antonella, et al.
Publicado: (2013)

Carbon-coated iron oxide nanoparticles as contrast agents in magnetic resonance imaging
por: Bae, Hongsub, et al.
Publicado: (2012)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

Quantitative Analysis of Microperfusion in Contrast-Induced Nephropathy Using Contrast-Enhanced Ultrasound: An Animal Study
por: Seo, Nieun, et al.
Publicado: (2021)

Targeted Imaging of Lung Cancer with Hyperpolarized (129)Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents
por: Kimura, Atsuomi, et al.
Publicado: (2022)

Key Parameters on the Microwave Assisted Synthesis of Magnetic Nanoparticles for MRI Contrast Agents
por: Brollo, Maria Eugênia Fortes, et al.
Publicado: (2017)

Application of spin-crossover water soluble nanoparticles for use as MRI contrast agents
por: Tsukiashi, Asami, et al.
Publicado: (2018)

Functionalized Gold Nanoparticles as Contrast Agents for Proton and Dual Proton/Fluorine MRI
por: Şologan, Maria, et al.
Publicado: (2019)

Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
por: Cai, Xiaoxia, et al.
Publicado: (2019)

Deep Learning-Based Automated Quantification of Coronary Artery Calcification for Contrast-Enhanced Coronary Computed Tomographic Angiography
por: Lee, Jung Oh, et al.
Publicado: (2023)

Single-Dose Gadoterate Meglumine for 3T Late Gadolinium Enhancement MRI for the Assessment of Chronic Myocardial Infarction: Intra-Individual Comparison with Conventional Double-Dose 1.5T MRI
por: Lim, Jiyeon, et al.
Publicado: (2018)

Usefulness of double dose contrast-enhanced magnetic resonance imaging for clear delineation of gross tumor volume in stereotactic radiotherapy treatment planning of metastatic brain tumors: a dose comparison study
por: Subedi, Kalloo Sharma, et al.
Publicado: (2013)

Amalgamation of complex iron(III) ions and iron nanoclusters with MWCNTs as a route to potential T(2) MRI contrast agents
por: Kuźnik, Nikodem, et al.
Publicado: (2015)

CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells
por: Rago, Gianluca, et al.
Publicado: (2011)

Magnetic properties of biofunctionalized iron oxide nanoparticles as magnetic resonance imaging contrast agents
por: Gervits, Natalia E, et al.
Publicado: (2019)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
por: Kim, So Yeon
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3p030omfofn79mri5mcrr87lf4